A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt)

NCT00435539 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Vitreomacular Traction

Interventions

DRUG: ocriplasmin
DRUG: ocriplasmin
DRUG: Sham Comparator

Sponsor

ThromboGenics